Peptide Atlas · Mineral

Ferric carboxymaltose

In the AFFIRM-AHF trial of 1,108 patients stabilised after acute heart failure with iron deficiency, intravenous ferric carboxymaltose lowered total heart failure hospitalisations against placebo (rate ratio 0.74) without changing cardiovascular death.

established

provisional
2 citations
0 discussions
0 followers
FCM
Ferinject
Injectafer
iron(III) carboxymaltose

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

established — replicated in humans, or settled by a regulator

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

No personal-experience post names it yet. When a member describes their own experience, PACIFIER reads it as such and it is listed here — labelled as experience, never as advice.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.